Advanced search
Start date

Evaluation of the effect of mesenchymal stem cells from healthy rats on the osteoblastic differentiation of mesenchymal stem cells from hypertensive rats

Grant number: 17/27036-6
Support Opportunities:Scholarships in Brazil - Scientific Initiation
Effective date (Start): March 01, 2018
Effective date (End): February 28, 2019
Field of knowledge:Health Sciences - Dentistry - Oral and Maxillofacial Surgery
Principal Investigator:Márcio Mateus Beloti
Grantee:Barbara Luana da Silva Bezerra
Host Institution: Faculdade de Odontologia de Ribeirão Preto (FORP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil


In addition to being a risk factor for cardiovascular diseases, being one of the major global health problems, hypertension has been associated with negative effects on bone tissue, leading to a decrease in bone mass and consequently greater susceptibility to fractures. Several drugs have been proposed in order to minimize this harmful effect and promote the best bone repair in healthy and hypertensive patients, improving their quality of life. Among the treatments, a promising alternative is the use of cell therapy, based on the use of mesenchymal stem cells (MSCs) and/or differentiated osteoblasts from these MSCs, to treat the damages to bone tissue caused by hypertension. Therefore, the aim of the present project will be to evaluate the influence of MSCs derived of normotensive/healthy rats on the osteoblastic differentiation of MSCs derived from hypertensive rats grown under osteogenic conditions using an indirect co-culture model. Bone marrow MSCs will be obtained from hypertensive (HA-MSCs) and normotensive/healthy rats (SAU-MSCs) and expanded in vitro in growth medium. Subsequently, indirect coculture will be performed in osteogenic medium using 24-well plates with inserts so that the inserts contain SAU-MSCs, while the HA-MSCs will be cultured at the bottom of the wells. The controls will be non-cocultured SAU-MSCs and HA-MSCs, grown alone in osteogenic medium, which will be compared to the HA-MSCs grown in indirect coculture with SAU-MSCs. The evaluated cellular responses will be cell proliferation, alkaline phosphatase activity (ALP), mineralized extracellular matrix formation and gene expression of the osteoblastic markers, RUNX2, osterix, ALP, bone sialoprotein and osteocalcin. The data will be submitted to the normal curve adherence test to determine the appropriate statistical test. The results of this study may contribute to determine the characteristics of candidate cells to be used in cell therapy in patients with arterial hypertension, since this is a global health issue. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.